資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/31758
|
| 標題: | Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan |
| 作者: | Wu, Pei-Ying
Cheng, Chien-Yu
Liu, Chun-Eng
Lee, Yi-Chien
Yang, Chia-Jui
Tsai, Mao-Song
Cheng, Shu-Hsing
Lin, Shih-Ping
Lin, De-Yu
Wang, Ning-Chi
Lee, Yi-Chieh
Sun, Hsin-Yun
Tang, Hung-Jen
Hung, Chien-Ching |
| 貢獻者: | Natl Taiwan Univ Hosp, Ctr Infect Control
Taoyuan Gen Hosp, Dept Internal Med, Minist Hlth & Welf
Natl Yang Ming Univ, Sch Publ Hlth
Changhua Christian Hosp, Dept Internal Med
Ditmanson Med FdnChia Yi Christian Hosp, Dept Internal Med
Natl Yang Ming Univ, Sch Med
Far Eastern Mem Hosp, Dept Internal Med
Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr
Taichung Vet Gen Hosp, Dept Internal Med
Triserv Gen Hosp, Dept Internal Med
Natl Def Med Coll
Lotung Poh Ai Hosp, Med Lo Hsu Fdn, Dept Internal Med
Natl Taiwan Univ Hosp, Dept Internal Med
Natl Taiwan Univ, Coll Med
Chi Mei Med Ctr, Dept Internal Med
Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
Natl Taiwan Univ, Dept Parasitol, Coll Med |
| 關鍵字: | Transmitted Drug-Resistance
Infected Patients
Risk-Factors
Hiv-1-Infected Patients
Adverse Events
Nevirapine Use
Hepatitis-C
Protease Inhibitors
Clinical-Trials
Virus-Infection |
| 日期: | 2017-02-21 |
| 上傳時間: | 2018-11-30 15:55:35 (UTC+8) |
| 出版者: | Public Library Science |
| 摘要: | Objectives Two nucleos(t) ide reverse-transcriptase inhibitors (NRTIs) plus 1 non-NRTI (nNRTI) remain the preferred or alternative combination antiretroviral therapy (cART) for antiretroviral-naive HIV-positive patients in Taiwan. The three most commonly used nNRTIs are nevirapine (NVP), efavirenz (EFV) and rilpivirine (RPV). This study aimed to determine the incidences of hepatotoxicity and skin rashes within 4 weeks of initiation of cART containing 1 nNRTI plus 2 NRTIs. Methods Between June, 2012 and November, 2015, all antiretroviral-naive HIV-positive adult patients initiating nNRTI-containing cART at 8 designated hospitals for HIV care were included in this retrospective observational study. According to the national HIV treatment guidelines, patients were assessed at baseline, 2 and 4 weeks of cART initiation, and subsequently every 8 to 12 weeks. Plasma HIV RNA load, CD4 cell count and aminotransferases were determined. The toxicity grading scale of the Division of AIDS (DAIDS) 2014 was used for reporting clinical and laboratory adverse events. Results During the 3.5-year study period, 2,341 patients initiated nNRTI-containing cART: NVP in 629 patients, EFV 1,363 patients, and RPV 349 patients. Rash of any grade occurred in 14.1% (n = 331) of the patients. In multiple logistic regression analysis, baseline CD4 cell counts (per 100-cell/mu l increase, adjusted odds ratio [AOR], 1.125; 95% confidence interval [95% CI], 1.031-1.228) and use of NVP (AOR, 2.443; 95% CI, 1.816-3.286) (compared with efavirenz) were independently associated with the development of skin rashes. Among the 1,455 patients (62.2%) with aminotransferase data both at baseline and week 4, 72 (4.9%) developed grade 2 or greater hepatotoxicity. In multiple logistic regression analysis, presence of antibody for hepatitis C virus (HCV) (AOR, 2.865; 95% CI, 1.439-5.704) or hepatitis B surface antigen (AOR, 2.397; 95% CI, 1.150-4.997), and development of skin rashes (AOR, 2.811; 95% CI, 1.051-7.521) were independently associated with the development of hepatotoxicity. Conclusions The baseline CD4 cell counts and use of NVP were associated with increased risk of skin rashes, while hepatotoxicity was independently associated with HCV or hepatitis B virus coinfection, and development of skin rashes in antiretroviral-naive HIV-positive Taiwanese patients within 4 weeks of initiation of nNRTI-containing regimens. |
| 關聯: | Plos One, v.12, n.2, e0171596 |
| 顯示於類別: | [保健營養系(所) ] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 10.1371-journal.pone.0171596.pdf | | 951Kb | Adobe PDF | 0 | 檢視/開啟 | | index.html | | 0Kb | HTML | 1335 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
